Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients

Transplant Immunology

Volumn 25, Issue 2-3, 2011, Pages 159-162

  Verleden, Stijn E ^a   Vandooren, Jennifer ^b   Vos, Robin ^a   Willems, Stijn ^a   Dupont, Lieven J ^a   Verleden, Geert M ^a   Van Raemdonck, Dirk E ^a   Opdenakker, Ghislain ^b   Vanaudenaerde, Bart M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Azithromycin; Lung transplantation; MMP 9; Neutrophils

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CYCLOSPORIN A; GELATINASE A; GELATINASE B; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; STEROID; TACROLIMUS;

ADULT; AIRWAY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GELATIN ZYMOGRAPHY; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MALE; NEUTROPHIL COUNT; NEUTROPHILIA; NEUTROPHILIC CHRONIC LUNG ALLOGRAFT DYSFUNCTION; NEUTROPHILIC REVERSIBLE ALLOGRAFT DYSFUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; TREATMENT DURATION; ZYMOGRAPHY;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RESPIRATORY SYSTEM;

EID: 80052331052     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.06.006     Document Type: Article

References (21)

1. Glanville A.R. Bronchoscopic monitoring after lung transplantation. Semin Respir Crit Care Med Apr 2010, 31(2):208-221.
2. Vanaudenaerde B.M., Meyts I., Vos R., Geudens N., De Wever W., Verbeken E.K., et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J Oct 2008, 32(4):832-843.
3. Vos R., Vanaudenaerde B.M., Verleden S.E., De Vleeschauwer S.I., Willems-Widyastuti A., Van Raemdonck D.E., et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J Jan 2011, 37(1):164-172.
4. Verleden G.M., Vanaudenaerde B.M., Dupont L.J., Van Raemdonck D.E. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med Sep 1 2006, 174(5):566-570.
5. Murphy D.M., Forrest I.A., Ward C., Corris P.A., Johnson G.E., Jones D., et al. Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts. Thorax Sep 2007, 62(9):834.
6. Vanaudenaerde B.M., Wuyts W.A., Dupont L.J., Van Raemdonck D.E., Demedts M.M., Verleden G.M. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant Nov 2003, 22(11):1280-1283.
7. Mertens V., Blondeau K., Pauwels A., Farre R., Vanaudenaerde B., Vos R., et al. Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci May 2009, 54(5):972-979.
8. Standardization of spirometry-1987 update. Official statement of American Thoracic Society. Respir Care Nov 1987, 32(11):1039-1060.
9. Estenne M., Maurer J.R., Boehler A., Egan J.J., Frost A., Hertz M., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant Mar 2002, 21(3):297-310.
10. Descamps F.J., Martens E., Opdenakker G. Analysis of gelatinases in complex biological fluids and tissue extracts. Lab Invest Nov 2002, 82(11):1607-1608.
11. Vandooren J., Geurts N., Martens E., Van den Steen P.E., Jonghe S.D., Herdewijn P., et al. Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain. World J Biol Chem Jan 26 2011, 2(1):14-24.
12. Hubner R.H., Meffert S., Mundt U., Bottcher H., Freitag S., El Mokhtari N.E., et al. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J Mar 2005, 25(3):494-501.
13. Taghavi S., Krenn K., Jaksch P., Klepetko W., Aharinejad S. Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant Jun 2005, 5(6):1548-1552.
14. Verleden S.E., Vos R., Mertens V., Willems-Widyastuti A., De Vleeschauwer S.I., Dupont L.J., et al. Heterogeneity of chronic lung allograft dysfunction: Insights from protein expression in broncho alveolar lavage. J Heart Lung Transplant Jun 2011, 30(6):667-673.
15. Kanai K., Asano K., Hisamitsu T., Suzaki H. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm Dec 2004, 13(5-6):313-319.
16. Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol Jan 2003, 28(1):12-24.
17. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol Dec 2002, 37(6):375-536.
18. Kanai K., Asano K., Hisamitsu T., Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J May 2004, 23(5):671-678.
19. Jain R., Danziger L.H. The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. Curr Pharm Des 2004, 10(25):3045-3053.
20. Vanaudenaerde B.M., Vos R., Meyts I., De Vleeschauwer S.I., Verleden S.E., Widyastuti-Willems A., et al. Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back. Inflamm Allergy Drug Targets Dec 2008, 7(4):279-287.
21. Vos R., Vanaudenaerde B.M., Ottevaere A., Verleden S.E., De Vleeschauwer S.I., Willems-Widyastuti A., et al. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?. J Heart Lung Transplant Dec 2010, 29(12):1358-1368.